Genetic Test Can Identify Triple Negative Breast Cancer Treatment

A test including 53 genes can predict who will respond and who will not respond to triple negative breast cancer immunotherapy.

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer

Triple-Negative Breast Cancer: Stages, Treatment, Prognosis

Genetic Test Can Identify Triple Negative Breast Cancer Treatment Responders

Biomarkers for Kidney Cancer Pinpointed

Triple-Negative Breast Cancer - Bridge Breast Network

How Common Is Triple-Positive Breast Cancer?

Castle Biosciences to Acquire Mental Health PGx Test Maker AltheaDx

Healthy Tissue Near Lung Tumors May Better Predict Lung Cancer Recurrence

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Immunotherapy Added to Chemotherapy Nearly Doubles Advanced Bladder Cancer Survival

Generative AI Used to Develop T Cell Cancer Immunotherapy

Chance Most Pathogenic Variants Will Actually Cause Disease Is Low

Researchers Develop Highly Sensitive PCR-Based Liquid Biopsy Cancer Dx